Physician profile
John Mullins
NPI 1396784377
$5,367.64
in general payments reported to CMS, 2019-2025
23 companies · $72.16 in 2025
The $72.16 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $172 · 2021: $389 · 2022: $2,320 · 2023: $1,813 · 2024: $103 · 2025: $72.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,385 · Food and Beverage: $603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,384.51 |
| Food and Beverage | $603.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $2,402.46 | 2022-2023 | |
| Intuitive Surgical, INC. | $1,209.23 | 2022 | |
| Silk Road Medical, INC. | $372.73 | 2020-2022 | |
| Lemaitre Vascular, INC. | $267.92 | 2022-2024 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome, Xenosure Biologic Patch |
| W. L. Gore & Associates, INC. | $221.53 | 2019-2023 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Bard Peripheral Vascular, INC. | $173.73 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Medistim USA, INC. | $124.88 | 2019 | |
| Penumbra, INC. | $117.71 | 2019 | |
| Tactile Systems Technology INC | $77.67 | 2019 | |
| Shockwave Medical, INC | $57.20 | 2022 | |
| Teleflex LLC | $55.10 | 2019 | |
| Boston Scientific Corporation | $43.67 | 2020-2022 | |
| Abbott Laboratories | $40.58 | 2023 | Diamondback Coronary |
| Medtronic, INC. | $34.64 | 2021 | |
| Janssen Pharmaceuticals, INC | $28.00 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $25.31 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $24.72 | 2020 | |
| Cook Medical LLC | $21.69 | 2019 | |
| Elutia, INC. | $15.67 | 2021 | |
| Daiichi Sankyo INC. | $15.53 | 2021 | |
| Medtronic Vascular, INC. | $13.71 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.04 | 2019 | |
| Pfizer INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mullins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.